CytoDyn Inc. Earnings Per Share Diluted

• CytoDyn Inc. showed an increase of +100.0% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on July 25, 2025.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), CytoDyn Inc.'s Earnings Per Share Diluted has grown by 100.0%.
• Historical annual values: Fiscal year 2025: $0.00 per share | Fiscal year 2024: $0.05 (loss) per share | Fiscal year 2023: $0.10 (loss) per share | Fiscal year 2022: $0.31 (loss) per share | Fiscal year 2021: $0.30 (loss) per share | Fiscal year 2020: $0.33 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026